Slide background

Extend your know-how from
the following conferences

// Conferences’ presentations 2017 are coming soon! //



Innovation management conferences

The best insight on Life Sciences environment

Life Sciences Ecosystem Trends and its Impact on Strategies

10:30 – 12:00 – Mondays, October 3rd, 2016
The current life sciences ecosystem is rife with trends making the industry and market, highly volatile. These trends have different impacts on the business models, performance, manufacturing & regulatory environment, mergers & acquisitions and ultimately, on innovation. In order to combat these trends, different strategies are adopted by organizations to have long-term growth opportunities. However, moving forward and beyond 2016 it’s important to understand the impact of trends in the life science industry and the strategies adopted by Life science companies.
Our panelist will give you unique insights and the major trends of the sector for the years to come.

Moderator: Stéphane Bazoche
Speakers: Eric Falcand, Laurent Nguyen, Christian Rohlff

Medical devices’ regulatory intelligence

13:00 – 14:00 – 12:00 – Mondays, October 3rd, 2016
Given the sharp increase in the number and complexity of medical device technologies on the market nowadays, Regulatory authorities are constantly reviewing this highly innovative industry, providing additional regulatory frameworks to ensure product safety and to mitigate risks. On a global scale, governments are increasingly adding to the regulatory burden for medical device manufacturers, resulting in regulatory teams that must continually adapt alongside changing regulatory environment.
Our panelists will help you to maintain a regulatory compliance throughout the medical device product lifecycle.

Moderator: Vincent Castéras
Speakers: Khalid Ishaque, Sophie Vaillot

Strategic Alliance Management

14:00 – 15:00 – Mondays, October 3rd, 2016
The externalization trend observed in the biopharmaceutical companies is a common response to the need for accessing innovation and leverage strategic alliance partnerships to gain market access, co-marketing, co-promotion, codevelopment… Setting mutual trust and keeping the relationship in good conditions require a good understanding of each organizations needs and objectives.
Learn from our panelists’ experience to successfully shape the negotiations.

Moderator: Harm-Jan Borgeld
Speakers: Jukka Muhonen, Stefanie Schubert, Annick De Swaef

The best outcomes from your innovation

From research projects to intellectual property management & exploitation of results

09:30 – 11:00 – Tuesday, October 4th, 2016
Given the R&D-driven nature of the Life Sciences field, forward-looking and sophisticated planning of the development and exploitation of IP is essential.
The main questions are:
– Which partners: industry and/or research institutes and hospitals.
– Ownership of the results: know-how, patents, co-ownership and contractual schemes.
– Exploitation of the results: license of the results, manufacture and distribution of health products.

Moderator: Wolfgang Rehmann
Speakers: Albert Barberà, Laurent Benel, Clarissa Ceruti, Aude Michel, Evelyne Friedel

Develop an entrepreneurship culture

11:30 – 12:30 – Tuesday, October 4th, 2016
Bioentrepreneurship is the process of creating value from life science innovation. The fundamental notion is about moving a life science discovery or invention from the research phase through development to commercialization. Bioentrepreneurs will discuss and debate their own vision in the aspects of:
– Diving in strategic and operational perspective of project management,
– Answering the requirements of all involved stakeholders,
– Planning cost-effective management.
Discuss your own vision to panelists’ ones during this session: What is a great Bioentrepreneur made of?

Moderator: Alan Edwards
Speakers: Sam Dukan, Hartmut Ehrlich, Manuel Gea

Where Innovation Providers and Innovation Developers meet

Promoting and selling your innovation

14:00 – 14:45 – Tuesday, October 4th, 2016
No matter what you are looking for: increasing investors’ interest, co-developing with partners or licensing opportunities, communication is a major asset for your reputation and the relay of your information will make your company interesting in the eyes of new partners. A good communication will raise the interest of potential investors or collaborators and could give you the means to succeed in your innovative project.
Benefit from our panelists feedback and insights on their successful communication strategy.

Moderator: Sara Núñez-García
Speakers: David Caumartin, Stephan Lensky

New ways & tools to detect and assess external innovation

14:45 – 15:30 – Tuesday, October 4th, 2016
Within a sector providing constant innovation, you should always be aware of the latest innovative projects arising in your strategic area of expertise. Innovation centers, technology detection platforms, scouting strategies, … represent new ways to accelerate project development and licensing opportunities.
Our panelists will present you their toolbox to detect and attract potential partners that meet with your objectives.

Moderator: Jean Derégnaucourt
Speakers: Kurt Hertogs, Montse Miralpeix, Vincent Serra

Financing an Innovative project

Mapping and typology of investors

16:00 – 17:00 – Tuesday, October 4th, 2016
Biotechnology companies are capital intensive corporations. Funding is the main issue to pursue research and development activities particularly in terms of the development of new molecules.
You would like to know the objectives and strategies of investors and why they would prefer to invest in one company rather than another?
Our Panelists will provide you the keys to understand the different roles and objectives of these funders and at what development stage you will get their interest.

Moderator: Guillaume Morelli
Speakers: Alessio Beverina, Jemila Houacine, Jeroen Bakker

Off sight & alternative funding resources for your project

17:00 – 17:45 – Tuesday, October 4th, 2016
Securing adequate funding for drug discovery and development programs continues to be challenging for the biotech industry. Usually, such funding has been raised through dilutive equity in often unpredictable public capital markets and/or by out-licensing key programs to big pharma, leaving biotech shareholders with only a fraction of the full value of their companies’ innovations. In response to these trends, a range of alternative financing sources have become available. Private donors answering specific patient populations’ needs, royalty monetizations, contract research organization (CRO)-linked financings and collaborative development financings, European grants and programs …; these and others are all claiming their place on the spectrum of healthcare financing.
Take part in this session to discover and engage with these new foundations, programs and private funders.

Speakers: Christian Girard, Katy Levitt



Digital conferences

Digital health: trends and perspectives

09:30 – 10:15 – Tuesday, October 4th, 2016

  • Current State of the market: key facts and figures.
  • Regulatory requirements/obstacles and ethical issues linked to the Life Sciences field.
  • Business models and Investments: lessons learned?
  • E-Health impact on the healthcare market.

Moderator: Nuno Godinho
Speakers: Patrice Cristofini, Andreas Lymberis

Build and develop your digital strategy

10:15 – 11:00 – Tuesday, October 4th, 2016

  • Don’t miss the digital transition in the healthcare industry: challenges, strategies and transformation.
  • Brand content management: the new strategic « weapon » of pharmaceutical industry?
  • Opportunities of digital marketing : impacts of user experience
  • Inbound Marketing VS Outbound Marketing: evolution and case studies.
  • Multichannel communication role in development of healthcare companies.
  • A future for healthcare virtual marketing?

Speakers: Carmen Chavarri, Davouth Op

Evolution from Big data to Smart Data: leverage for healthcare companies

11:15 – 12:15 – Tuesday, October 4th, 2016

  • Challenges of Big Data in the healthcare market : between innovation, laws and ethics.
  • Exponential partnership growth between information technology and pharmaceutical industries : general assesments and trends (case studies: Google and Sanofi, Biogen…).
  • Innovation through usage: what is smart data?
  • « Blockchain », the future of big data?

Moderator: Shahid Hanif
Speakers: Matej Adam, Hartwig Jaeger


Patient and care giver empowerement in the value chain

14:00 – 15:00 – Tuesday, October 4th, 2016

  • The connected patient: from authoritative to collaborative health professionals.
  • Practice and healthcare safety on the web.
  • BtoB and BtoC promotion: challenges and opportunities.
  • How Intelligent Patient Platforms transform the patient care coordination.

Moderator: Jean-Marc Bourez
Speakers: Samantha Beneyto, Carlos Jaime

How is « uberization » affecting health industry

15:00 – 16:00 – Tuesday, October 4th, 2016

  • The disruption of health by Artificial Intelligence and Algorithms in the next decade.
  • « Uberization » of health: between reality and fantasy.
  • Transformation of epidemiologic and medical reasearch.

Moderator: Waseem Sharifs
Speakers: Gillian Holdsworth, Nicolas Méric

M-Health & IoT: what role in health organizations?

16:30 – 17:30 – Tuesday, October 4th, 2016

  • 2016’s: Best health apps.
  • M-Health: Disruptive trend of health logistics?
  • How can R&D leverage m-health and its tools?
  • Safety, interoperability and intraoperability: tomorrow’s challenges.

Moderator: Jim Morrish
Speakers: Pierre Leurent, Alexis Normand, Emmanuelle Pierga

*